Lymphoblastic Leukemia, Acute, With Lymphomatous Features; Lall

Clinical Features

Phenotypes and symptoms related to Lymphoblastic Leukemia, Acute, With Lymphomatous Features; Lall

  • Lymphoma
  • T-cell acute lymphoblastic leukemias

Incidence and onset information

Not enough data available about incidence and published cases.
No data available about the known clinical features onset.

Alternative names

Lymphoblastic Leukemia, Acute, With Lymphomatous Features; Lall Is also known as lymphomatous all.

Researches and researchers

Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.


Mendelian

Accelerate your rare disease diagnosis with us

Learn more

Lymphoblastic Leukemia, Acute, With Lymphomatous Features; Lall Recommended genes panels

Panel Name, Specifity and genes Tested/covered
JAK2 Genotyping (V617F).

By Molecular Genetics Diagnostic Laboratory Detroit Medical Center University Laboratories (United States).

JAK2
Specificity
100 %
Genes
15 %
JAK2 Exon 12 Sequencing.

By Molecular Genetics Diagnostic Laboratory Detroit Medical Center University Laboratories (United States).

JAK2
Specificity
100 %
Genes
15 %
MyeloidDx by NGS.

By Molecular Genetics Diagnostic Laboratory Detroit Medical Center University Laboratories (United States).

RUNX1, SF3B1, SRSF2, BRAF, SMC1A, STAG2, TP53, U2AF1, KDM6A, WT1, IKZF1, CALR, CBL, CBLB, SETBP1, FBXW7, CDKN2A, PHF6, ASXL1, CEBPA , (...)

View the complete list with 32 more genes
Specificity
6 %
Genes
43 %
MyeloidDx by NGS.

By Molecular Genetics Diagnostic Laboratory Detroit Medical Center University Laboratories (United States).

RUNX1, SF3B1, SRSF2, BRAF, SMC1A, STAG2, TP53, U2AF1, KDM6A, WT1, IKZF1, CALR, CBL, CBLB, SETBP1, CBLC, FBXW7, CDKN2A, PHF6, CEBPA , (...)

View the complete list with 31 more genes
Specificity
6 %
Genes
43 %
JAK2 V617F Quantitative Assay.

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).

JAK2
Specificity
100 %
Genes
15 %
Thrombocytosis Panel by next generation sequencing (NGS).

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).

THPO, CALR, JAK2, MPL
Specificity
25 %
Genes
15 %
Erythrocytosis Panel by next-generation sequencing (NGS).

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States).

BPGM, EGLN1, VHL, EPAS1, EPOR, HBA1, HBA2, HBB, JAK2
Specificity
12 %
Genes
15 %
JAK2. Complete sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica (Spain).

JAK2
Specificity
100 %
Genes
15 %

We have 327 more panels available in our App

Get the app

Sources and references

You can check the following sources for additional information.

OMIM MESH Genetic Syndrome Finder

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like WAARDENBURG SYNDROME, TYPE 4B; WS4B SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE INTERSTITIAL LUNG AND LIVER DISEASE; ILLD EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE; EBSDM MELNICK-NEEDLES SYNDROME; MNS CHYLOMICRON RETENTION DISEASE; CMRD ALPHA/BETA T-CELL LYMPHOPENIA WITH GAMMA/DELTA T-CELL EXPANSION, SEVERE CYTOMEGALOVIRUS INFECTION, AND AUTOIMMUNITY

Need help with a diagnosis?

Learn more about how to achieve it with Mendelian


Learn more